Soc. Generale Knock-Out PSX/ DE000SU400E9 /
| 2024-06-17 2:44:02 PM | Chg.-0.180 | Bid3:51:09 PM | Ask3:51:09 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.550EUR | -24.66% | 0.730 Bid Size: 35,000 |
0.750 Ask Size: 35,000 |
Phillips 66 | 129.3488 USD | 2078-12-31 | Call |
GlobeNewswire
1:00 PM
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
06-12
Greystone Closes $22.9 Million in Total Debt Placement and Preferred Equity Financing for Fort Worth...
GlobeNewswire
06-05
EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
05-29
Phillips Edison & Company to Present at Nareit REITweek 2024 Investor Conference
GlobeNewswire
05-22
Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention
GlobeNewswire
05-20
Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease We...
GlobeNewswire
05-16
Optimal Daily Dairy Consumption Remains Elusive Despite Well-Established Health Benefits
GlobeNewswire
05-16
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Newsfile Corp
05-15
King Fuels Announces Strategic Expansion of Its Fuel Distribution Network in Texas, Colorado, Kansas...
GlobeNewswire
05-14
Kontrolmatik Technologies and Pomega Standardize Operations With Siemens Solutions and Form an Engin...
GlobeNewswire
05-13
Safe Boating Campaign’s Annual National Safe Boating Week Celebrates All Boaters This May 18-24, 202...
GlobeNewswire
05-10
First Wave BioPharma, Inc. to raise approximately $1.1 million of Gross Proceeds Priced At-the-Marke...
GlobeNewswire
05-09
First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness ...
GlobeNewswire
05-08
Phillips Edison & Company Announces Pricing of Offering of $350 Million Aggregate Principal Amount o...
